Home >>Webcast>>Infertility & ART

Thursday, November 12, 2009

18:30-20:00

Welcome Reception

 
 

Friday, November 13, 2009

 

08:30-10:00	Keynote Lectures Advances in Obstetrics, Gynecology and Infertility: Leaders' Views on the Future
Capsule	What does the future hold for our main subdisciplines?
Chairpersons	Z. Ben-Rafael, Israel V. Gomel, Canada G.C. Di Renzo, Italy
08:30-09:00	Fetomaternal Medicine Intrauterine stem cell transplantation T-H. Bui, Sweden
09:00-09:30	Gynecology Surgical approach for endometriosis, do we have limits? F. Nezhat, USA
09:30-10:00	Infertility & ART The Future of In Vitro Maturation (IVM) R. Fadini, Italy
10:00-10:30	Coffee break
10:30-12:30	Fostimon, human-type FSH: From basic science to clinical practice Sponsored by IBSA Institut Biochimique SA
Chairpersons	Z.J. Chen, China J.L.H. Evers, The Netherlands V. Gomel, Canada
10:30-10:35	Introduction
10:35-10:55	A critical review of the gonadotrophins used for ovarian stimulation in IVF S. Daya, Canada
10:55-11:15	Structure-activity relationship of FSH molecular species: Focus on glycosylation M. Dattilo, Switzerland
11:15-11:35	Effect of FSH stimulation regimens on the pattern of mRNA expression in human cumulus cells M. Benkhalifa, France
11:35-11:55	Fostimon’s human type FSH: Clinical results G. D’amato, Italy
11:55-12:15	Human type FSH: The impact on the cost of treatment S. Gerli, Italy
12:15-12:30	Discussion and conclusions
12:30-13:30	Lunch break
13:30-15:30	Cryopreservation of Gametes and Ovaries
Capsule	The best clinical method for cryopreservation of oocytes and ovarian tissue is yet to be decided
Chairperson	S.A. Carson, USA J. Donnez, Beligum
13:30-14:30	Debate Human Oocyte Cryopreservation: Slow Freezing or Verification Techniques Human oocyte cryopreservation: The slow-freezing technique A. Borini, Italy Human oocyte cryopreservation: Vitrification technique R. Fadini, Italy
14:30-15:00	Freezing whole human ovaries P. Patrizio, USA
15:00-15:30	The advantages of zygote vitrification T. Cordes, Germany
15:30-16:00	Coffee Break
16:00-18:00	Assessment of Ovarian Reserve
Capsule	Decreased ovarian reserve remains a common and frustrating condition despite years of experience. Can we evaluate and provide better treatment?
Chairpersons	K. Diedrich, Germany  I.E. Messinis, Greece C.Q. Zhou, China
16:00-16:25	Should we routinely perform tests for ovarian reserve? A. Maheshwari, UK
16:25-16:50	What does DHEA have to do with treating diminished ovarian reserve? N. Gleicher, USA
16:50-17:15	Can we rejuvenate defective aged oocytes by ooplasm replacement using germinal vesicle transfer? K. Kawano, Japan
17:15-18:00	Debate Proposition: No treatment options for decreased ovarian reserve and low responders are effective. It is only cycle-to-cycle variation that is of importance! P. Patrizio, USA Opposition: Better protocols will result in better pregnancy rates! S. Daya, Canada Discussion
Saturday, November 14, 2009
08:30-10:00	Clinical Application of the Gamete Freezing
Capsule	The rising efficacy of gamete freezing facilitates diversification of clinical solutions Organized and endorsed by IVI (Instituto Valenciano de Infertilidad)
Chairpersons	P. Patrizio USA A. Requena, Spain
08:30-09:00	What vitrification adds to difficult IVF cases in low and high responders? I. Ortega, Spain
09:00-09:30	Delaying childbearing: An increasing demand for egg freezing A. Requena, Spain
09:30-10:00	What are the reproductive options for males suffering from cancer? N. Garrido, Spain
10:00-10:30	Coffee Break
10:30-12:30	Hot Controversies - Expert Opinion on: Clinical Aspects of ART
Capsule	Expert opinions on controversial topics
Chairpersons	Z. Ben-Rafael, Israel K. Diedrich, Germany
	Z.J. Chen, China S.A. Carson, USA J. Qiao, China N. Gleicher, USA S. Daya, Canada G. Kovacs, Australia
Questions	> Evidence based supplementation of the corpus luteum in IVF? > Minimal monitoring of ovarian stimulation: Is it safe? How minimal? > Cheap or expensive FSH preparations? > Why did the antagonist not replace the agonist? > Do we need the addition of luteinizing hormone (LH) for ovarian stimulation? > Risk of ovarian hyperstimulation syndrome (OHSS): Is it a real problem? > Intracytoplasmic sperm injection (ICSI) for all patients? > Is rescue ICSI effective in conventional IVF or ICSI? > Assisted zona hatching: What is the evidence? > Embryo transfer (ET); Do we really need US? > Is the ET technique important? > Single embryo transfer (SET) for all? > Is there a risk of cancer after ovarian stimulation?
12:30-13:30	Lunch break
13:30-15:30	Infertility Practice
Capsule	Many practical issues are still unsettled
Chairpersons	S. Daya, Canada G. Kovacs, Australia
13:30-14:00	Ovarian cortex cryopreservation and transplantation: Advantages and perils! J. Donnez, Belgium
14:00-14:30	Control of LH secretion in PCOS K. Ntafopoulos, Greece
14:30-15:00	The role of LH in ovarian stimulation I.E. Messinis, Greece
15:00-15:30	Metabolic Characteristics in PCOS in China Z.J. Chen, China
15:30-16:00	Coffee Break
16:00-18:00	Polycystic Ovarian Syndrome (PCOS) in the Asia-Pacific Region
Capsule	Disagreement regarding basic criteria for definition of PCOS, are also region dependent? Organized and endorsed by The Asia and Oceana Federation of Obstetrics and Gynecology (AOFOG)
Chairpersons	P.C. Ho, Hong Kong N. Gleicher, USA Z.J. Chen, China
16:00-16:45	Views: Do we need a different set of criteria for defining PCOS in this region? Views from East Asia M. Hsu, Taiwan Views from South Asia D. Shah, India Discussion
16:45-17:30	Views: Do we need different treatment for Asian PCOS? J.Tank, India J. Qiao, China Discussion
17:30-18:00	Can we prevent OHSS syndrome? H. Sallam, Egypt
18:30-20:00	"Voices" Special Entertainment Lecture by Dr. C.O. (Skip) Granai, USA
Sunday, November 15, 2009
08:30-10:00	In-Vitro Maturation (IVM)
Capsule	Despite many improvements, IVM is still experimental: Risk benefits and pitfalls should be clarified
Chairpersons	A. Borini, Italy E. Ng, Hong Kong
08:30-09:30	Debate Will IVM Ever Replace Standard IVF? Yes: IVM should be an integral part of IVF Service M. Leong, Hong Kong No: IVM does not offer any advantage over current IVF practice K.R. Held, Germany
09:30-10:00	How should selection of women be improved, and their IVM cycles optimized? R. Fadini, Italy
10:00-10:30	Coffee break
10:30-12:30	Increasing Success Rate in ART
Capsule	Can better laboratory techniques bring about a breakthrough in success rate? Organized and endorsed by The Asia and Oceana Federation of Obstetrics and Gynecology (AOFOG)
Chairpersons	H.N. Sallam, Egypt M. Leong, Hong Kong
10:30-11:30	Debate The end of the Preimplantation Genetic Screening (PGS) Era? Pros: PGS is associated with lower success rate and should not be offered as a screening tool! N. Gleicher, USA Cons: PGS has a role provided it correctly performed! K.R. Held, Germany
11:30-12:00	What can be achieved by acupuncture in assisted reproduction? E. Ng, Hong Kong
12:00-12:30	Does OHSS impair endometrial receptivity? P.C. Ho, Hong Kong